Hypoxia-inducible factor 1-a-AA-modified bone marrow stem cells protect pc12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway

Stem Cells and Development

Volumn 21, Issue 14, 2012, Pages 2703-2717

  Zhong, Qian ^a,b   Zhou, Yanfang ^a,c   Ye, Weibiao ^a   Cai, Tuo ^a   Zhang, Xiuquan ^d   Deng, David Y B ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SURVIVIN; TRANSCRIPTION FACTOR FKHR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DNA BINDING; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STEM CELL TRANSPLANTATION; UPREGULATION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL HYPOXIA; CEREBRAL INFARCTION; COBALT; COCULTURE TECHNIQUES; FORKHEAD TRANSCRIPTION FACTORS; GREEN FLUORESCENT PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LENTIVIRUS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURONS; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEM CELLS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863882273     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0604     Document Type: Article

References (54)

1. Donnan GA, M Fisher, M Macleod and SM Davis. (2008). Stroke. Lancet 371:1612-1623. (Pubitemid 351626845)
2. The world health report 2004. (2004). Annex Table 2: Deaths by cause, sex, and mortality stratum in WHO regions, estimates for 2002. World Health Organization.
3. Perasso L, CE Cogo, D Giunti, C Gandolfo, P Ruggeri, A Uccelli and M Balestrino. (2010). Systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo (2VO). Neural Plast 2010: 534925.
4. Lu J, S Moochhala, XL Moore, KC Ng, MH Tan, LK Lee, B He, MC Wong and EA Ling. (2006). Adult bone marrow cells differentiate into neural phenotypes and improve functional recovery in rats following traumatic brain injury. Neurosci Lett 398:12-17.
5. Chen X, Y Li, L Wang, M Katakowski, L Zhang, J Chen, Y Xu, SC Gautam and M Chopp. (2002). Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22:275-279. (Pubitemid 36142758)
6. Chopp M, Y Li and J Zhang. (2008). Plasticity and remodeling of brain. J Neurol Sci 265:97-101.
7. Ikeda N, N Nonoguchi, MZ Zhao, T Watanabe, Y Kajimoto, D Furutama, F Kimura, M Dezawa, RS Coffin, et al. (2005). Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 36:2725-2730.
8. Kurozumi K, K Nakamura, T Tamiya, Y Kawano, M Kobune, S Hirai, H Uchida, K Sasaki, Y Ito, et al. (2004). BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9:189-197. (Pubitemid 38256545)
9. Zhao MZ, N Nonoguchi, N Ikeda, T Watanabe, D Furutama, D Miyazawa, H Funakoshi, Y Kajimoto, T Nakamura, et al. (2006). Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 26:1176-1188. (Pubitemid 44268180)
10. Sharp FR and M Bernaudin. (2004). HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437-448. (Pubitemid 38715511)
11. Iyer NV, SW Leung and GL Semenza. (1998). The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 52:159-165. (Pubitemid 28465662)
12. Ivan M, K Kondo, H Yang, W Kim, J Valiando, M Ohh, A Salic, JM Asara, WS Lane and WG Kaelin, Jr. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464-468. (Pubitemid 32335941)
13. Jaakkola P, DR Mole, YM Tian, MI Wilson, J Gielbert, SJ Gaskell, A Kriegsheim, HF Hebestreit, M Mukherji, et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472. (Pubitemid 32335942)
14. Masson N, C Willam, PH Maxwell, CW Pugh and PJ Ratcliffe. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20:5197-5206. (Pubitemid 32910914)
15. Hu CJ, LY Wang, LA Chodosh, B Keith and MC Simon. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374. (Pubitemid 37499822)
16. Wang X, C Li, Y Chen, Y Hao, W Zhou, C Chen and Z Yu. (2008). Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun 371:283-288.
17. Giaccia A, BG Siim and RS Johnson. (2003). HIF-1 as a target for drug development. Nat Rev Drug Discov 2:803-811. (Pubitemid 37361812)
18. Dai Y, M Xu, Y Wang, Z Pasha, T Li and M Ashraf. (2007). HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42:1036-1044. (Pubitemid 46829200)
19. Vangeison G, D Carr, HJ Federoff and DA Rempe. (2008). The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 28:1988-1993. (Pubitemid 351302661)
20. Colter DC, I Sekiya and DJ Prockop. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98:7841-7845. (Pubitemid 32642648)
21. Polak M, R Scharfmann, B Seilheimer, G Eisenbarth, D Dressler, IM Verma and H Potter. (1993). Nerve growth factor induces neuron-like differentiation of an insulinsecreting pancreatic beta cell line. Proc Natl Acad Sci U S A 90:5781-5785. (Pubitemid 23176246)
22. Tang XQ, JQ Feng, J Chen, PX Chen, JL Zhi, Y Cui, RX Guo and HM Yu. (2005). Protection of oxidative preconditioning against apoptosis induced by H2O2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res 1057:57-64. (Pubitemid 41338087)
23. Alsayed Y, H Ngo, J Runnels, X Leleu, UK Singha, CM Pitsillides, JA Spencer, T Kimlinger, JM Ghobrial, et al. (2007). Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109:2708-2717. (Pubitemid 46482062)
24. Longa EZ, PR Weinstein, S Carlson and R Cummins. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 21:89-91.
25. Belayev LAO, R Busto, W Zhao and MD Ginsberg. (1996). Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27:1616-1622.
26. Puurunen K, J Jolkkonen, J Sirvio, A Haapalinna and J Sivenius. (2001). Selegiline combined with enrichedenvironment housing attenuates spatial learning deficits following focal cerebral ischemia in rats. Exp Neurol 167: 348-355. (Pubitemid 32150892)
27. An WG, M Kanekal, MC Simon, E Maltepe, MV Blagosklonny and LM Neckers. (1998). Stabilization of wildtype p53 by hypoxia-inducible factor 1alpha. Nature 392:405-408.
28. Ambrosini G, C Adida and DC Altieri. (1997). A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921. (Pubitemid 27353455)
29. Chen J, Y Li, M Katakowski, X Chen, L Wang, D Lu, M Lu, SC Gautam and M Chopp. (2003). Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778-786. (Pubitemid 37071731)
30. Deng YB, QT Yuan, XG Liu, XL Liu, Y Liu, ZG Liu and C Zhang. (2005). Functional recovery after rhesus monkey spinal cord injury by transplantation of bone marrow mesenchymal-stem cell-derived neurons. Chin Med J (Engl) 118:1533-1541. (Pubitemid 41404203)
31. Forsythe JA, BH Jiang, NV Iyer, F Agani, SW Leung, RD Koos and GL Semenza. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol 16:4604-4613 (Pubitemid 26272112)
32. Deng YB, WB Ye, ZZ Hu, Y Yan, Y Wang, BF Takon, GQ Zhou and YF Zhou. (2008). Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurol Res 32:148-156.
33. Gerber HP, F Condorelli, J Park and N Ferrara. (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/ KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667. (Pubitemid 27410939)
34. Chopp M and Y Li. (2002). Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92-100. (Pubitemid 37163494)
35. Dharmasaroja P. (2009). Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 16:12-20.
36. Wang Y, Y Deng and GQ Zhou. (2008). SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195:104-112.
37. Yilmaz G, JS Alexander, C Erkuran Yilmaz and DN Granger. (2010). Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue. Exp Transl Stroke Med 2:11.
38. Solaroglu I, A Solaroglu, E Kaptanoglu, S Dede, A Haberal, E Beskonakli and K Kilinc. (2003). Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22. (Pubitemid 36798745)
39. Rousseau S, F Houle, J Landry and J Huot. (1997). p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177. (Pubitemid 27493906)
40. Neufeld G, T Cohen, S Gengrinovitch and Z Poltorak. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22. (Pubitemid 29038270)
41. Oosthuyse B, L Moons, E Storkebaum, H Beck, D Nuyens, K Brusselmans, J Van Dorpe, P Hellings, M Gorselink, et al. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28:131-138. (Pubitemid 32538057)
42. Shin S, BJ Sung, YS Cho, HJ Kim, NC Ha, JI Hwang, CW Chung, YK Jung and BH Oh. (2001). An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 40:1117-1123 (Pubitemid 32108606)
43. Conway EM, F Zwerts, V Van Eygen, A DeVriese, N Nagai, W Luo and D Collen. (2003). Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxiainduced up-regulation. Am J Pathol 163:935-946. (Pubitemid 37040129)
44. Li Y, ZL Xia and LB Chen. (2011). HIF-1-alpha and survivin involved in the anti-apoptotic effect of 2ME2 after global ischemia in rats. Neurol Res 33:583-592.
45. Johnson EA, SI Svetlov, BR Pike, PJ Tolentino, G Shaw, KK Wang, RL Hayes and JA Pineda. (2004). Cell-specific upregulation of survivin after experimental traumatic brain injury in rats. J Neurotrauma 21:1183-1195. (Pubitemid 39280845)
46. Dimmeler S and AM Zeiher. (2000). Akt takes center stage in angiogenesis signaling. Circ Res 86:4-5. (Pubitemid 30044160)
47. Wang Z, C Jiang, H Ganther and J Lu. (2001). Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res 61:7171-7178. (Pubitemid 32946511)
48. Dormond O, JC Madsen and DM Briscoe. (2007). The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem 282:23679-23686. (Pubitemid 47311969)
49. Podar K, YT Tai, FE Davies, S Lentzsch, M Sattler, T Hideshima, BK Lin, D Gupta, Y Shima, et al. (2001). Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood 98:428-435.
50. Obsil T and V Obsilova. (2008). Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27:2263-2275. (Pubitemid 351501778)
51. Greer EL and A Brunet. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410-7425. (Pubitemid 41637981)
52. Tang ED, G Nunez, FG Barr and KL Guan. (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274:16741-16746.
53. Tran H, A Brunet, EC Griffith and ME Greenberg. (2003). The many forks in FOXO's road. Sci STKE 2003:RE5.
54. Guha M, J Plescia, I Leav, J Li, LR Languino and DC Altieri. (2009). Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res 69:4954-4958.